Design the financing path, not just the first round

Academic start-ups are the subject of the final judgment here: how should a research-based venture move from uncertain idea to company, then from company to durable financing? The evidence supports a sequence answer rather than a verdict for or against grants. Early support can change whether a project becomes a formal company, but the later path depends on whether the first round also creates the technical evidence, commercial capability, and relationships that the next source of capital requires.

The answer is a handoff, not a universally best instrument

The German evaluation of the EXIST–Business Startup Grant provides the clearest evidence for the first transition. Near the programme’s expert-score funding boundary, funded projects were much more likely to form a qualifying company than close projects that did not receive the intervention. Across the study’s specifications, the estimated odds ratios range from 4.83 to 10.79, with adjusted probability differences from 39.71 to 53.29 percentage points. Under the regression-discontinuity assumptions, this is a strong local causal result: a targeted, university-integrated grant can make the transition into formal company existence substantially more likely for projects near that threshold.

That finding answers an important question, but not the whole one. The EGS outcome is company formation, measured through qualifying entries in the German Commercial Register. It does not establish that every funded project survives, reaches revenue, attracts private equity, scales, or produces a successful exit. Nor does the design identify which part of the support bundle—living support, materials, coaching, university facilities, mentoring, or networks—causes the observed formation effect. A grant can be highly additional at the beginning of a venture’s life while leaving later commercial and financial problems unresolved.

The broader OECD evidence explains why. Across 81,318 start-ups in OECD countries, including 8,065 with an academic founder, academic start-ups are more likely to receive some funding after observed characteristics are controlled for, but they do not raise more overall. Their first funding amounts are similar to those of comparable non-academic start-ups, while their follow-on funding is lower. They are more likely to receive grants and assistance early, and the first financing modality is associated with what follows. Initial grants are associated with repeat grants, weaker transitions to equity, lower follow-on amounts, and lower probabilities of later-stage funding or acquisition than initial assistance. Those are trajectory relationships, not a causal verdict that grants harm companies.

The two findings fit together once the objective changes over time. Before formation, the binding constraint may be personal runway, prototype materials, or the ability to spend concentrated time testing an uncertain idea. A non-dilutive grant can absorb part of that risk without forcing a premature valuation or ownership transfer. After formation, the binding constraint may be different: a customer, regulatory milestone, manufacturing capability, investor relationship, or a larger capital requirement. The same grant that was appropriate for the first state may be insufficient for the second.

This is why “grant versus equity” is the wrong final comparison. The relevant comparison is between the bottleneck the venture has now and the transition it must make next. Assistance may be more valuable than more grant money when the missing asset is commercial knowledge, industry access, facilities, or investor introductions. Equity may be appropriate when the company can show a credible growth route and can accept dilution in exchange for capital and a financially interested partner. Debt may fit a more mature venture with a realistic repayment capacity, but it can be dangerous when revenue is still uncertain.